Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial

C Criscitiello, HA Azim Jr, D Adbor-tarh, E de Azambuja, M Piccart, J Baselga, H Eidtmann, S Di Cosimo, Ian Bradbury, IT Rubio

    Research output: Contribution to journalArticle

    22 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1980-1985
    JournalAnnals of Oncology
    Volume24
    Issue number8
    DOIs
    Publication statusPublished - 2013

    Cite this

    Criscitiello, C., Azim Jr, HA., Adbor-tarh, D., de Azambuja, E., Piccart, M., Baselga, J., Eidtmann, H., Di Cosimo, S., Bradbury, I., & Rubio, IT. (2013). Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial. Annals of Oncology, 24(8), 1980-1985. https://doi.org/10.1093/annonc/mdt129